CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,431,111
- in 18 filings, $21.0M under 10b5-1 plans
Net −$21,431,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Quinlan Paul T −$2.6M General Counsel sold 49% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-02-05 | BREWER RICHARD B Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 | ||
| 2010-02-05 | LOVE TED W Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 | ||
| 2010-02-05 | FREYTAG J WILLIAM Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 | ||
| 2009-10-14 | BRISTOW MICHAEL R President and CEO | Exercise or conversion | +7,394 | $0.06 | $444 | 280,071 |
| 2009-10-14 | BRISTOW MICHAEL R President and CEO | Exercise or conversion · Option to Purchase Common Stock | −7,394 | 0 | ||
| 2009-07-21 | Lowe David George Director | Sale | −78,800 | $3.94 | $310K | 129,600 |
| 2009-07-20 | Lowe David George Director | Sale | −102,000 | $4.44 | $453K | 208,400 |
| 2009-07-17 | Lowe David George Director | Sale | −25,000 | $4.19 | $105K | 310,400 |
| 2009-06-25 | FALBERG KATHRYN E CFO and COO | Grant or award · Option to purchase common stock | +50,000 | 50,000 | ||
| 2009-06-16 | FALBERG KATHRYN E CFO and COO | Sale | −2,200 | $3.58 | $8K | 18,800 |
| 2009-06-16 | FALBERG KATHRYN E CFO and COO | Sale | −6,000 | $3.59 | $22K | 12,800 |
| 2009-06-16 | FALBERG KATHRYN E CFO and COO | Sale | −100 | $3.60 | $360 | 12,700 |
| 2009-06-16 | FALBERG KATHRYN E CFO and COO | Sale | −6,700 | $3.61 | $24K | 6,000 |
| 2009-06-16 | FALBERG KATHRYN E CFO and COO | Sale | −500 | $3.62 | $2K | 5,500 |
| 2009-06-16 | FALBERG KATHRYN E CFO and COO | Sale | −1,600 | $3.62 | $6K | 3,900 |
| 2009-06-16 | FALBERG KATHRYN E CFO and COO | Sale | −200 | $3.64 | $728 | 3,700 |
| 2009-06-16 | FALBERG KATHRYN E CFO and COO | Sale | −500 | $3.65 | $2K | 3,200 |
| 2009-06-16 | FALBERG KATHRYN E CFO and COO | Sale | −1,400 | $3.66 | $5K | 1,800 |
| 2009-06-16 | FALBERG KATHRYN E CFO and COO | Sale | −1,300 | $3.67 | $5K | 500 |
| 2009-06-16 | FALBERG KATHRYN E CFO and COO | Sale | −500 | $3.68 | $2K | 0 |
Page 29 of 41 · 802 trades